MYCOVERSE Logo

Crested Milk Cap – the blood sugar-lowering mushroom

Coprinus comatus – Shaggy Mane – Sasakure Hitoyotake – Ji Tui Mo – Mao Tou Gui San

Bioactive ingredients

L-Ergothioneine – The Super Antioxidant

Powerful antioxidant – protects cells from oxidative stress

Neuroprotective – Protection of nerve cells

Anti-inflammatory – Reduction of chronic inflammatory processes

Tumor-suppressing – Anticarcinogenic properties

Comatin – The Diabetes Specialist

Antidiabetic – Blood sugar regulation

Antihyperglycemic – Control of elevated blood sugar levels

Lipid-lowering – reduction of cholesterol and triglyceride levels

HIV-1 Inhibition – Antiviral Effect

Vanadium – The Insulin Mimic

Insulin-mimetic – Enhancement of the blood-sugar-lowering effect by mimicking insulin

Antioxidant – Protection against free radicals

Antimicrobial – Inhibition of pathogenic microorganisms

Coprin – The Mycotoxin

Acetaldehyde dehydrogenase inhibition

Vitamin C – The Cell Protector

Antioxidant – Protection against oxidative damage

Trehalose – The Gut Care Specialist

Prebiotic – Promotes healthy gut flora

Citric Acid – The Blood Sugar Regulator

Antidiabetic – Supports blood sugar control

CCP (Coprinus comatus polysaccharides, β-glucans) – The All-Rounders

Prebiotic – Supports gut flora

Antidiabetic – Blood sugar regulation

Antioxidant – Cell protection

Anti-inflammatory – Anti-inflammatory effect

Hepatoprotective – Protects liver cells

Antibacterial – Antimicrobial Properties

Antimicrobial compounds – The germ fighters

Coprinin, coprinol – formed during fermentation

Coprinuslactone – Additional antimicrobial effect

Laccase – The HIV Inhibitor

Inhibition of HIV-1 activity – Limited antiviral effect

Phenols and aromatic molecules – The Relaxants

3-Octanone, 3-Octanol, 1-Octen-3-ol, 1-Octanol, l-Dodecanol

Antioxidant – Cell protection

Antitumor – Cancer-inhibiting properties

Emotional Relief – Reducing Anxiety and Promoting Relaxation After Extraction

Caprylic acid, n-butyric acid, isobutyric acid – Additional therapeutic components

Nutritional Profile – The Nutrition Package

Macronutrients:

Moisture content: 90.5%

Protein: 11.8–29.5 g/100 g

Fat: 1.1–7.3 g per 100 g

Carbohydrates: 32.1–76.3 g/100 g

Dietary fiber: 21.13–34.59 g/100 g

Ash: 13.24 g/100 g

Minerals:

Iron (Fe)

Calcium (Ca)

Zinc (Zn)

Magnesium (Mg)

Phosphorus (P)

Therapeutic Applications

Type 1 and Type 2 Diabetes Mellitus – The Blood Sugar Regulator

Promising results in animal studies

Reducing Insulin Resistance – Improvements in Type 2 Diabetes

Islet cell protection – Protection of pancreatic β-cells in type 1 diabetes

Blood Sugar Control – Lowering Fasting and Postprandial Blood Sugar Levels

Fructosamine Reduction – Improvement in Long-Term Blood Sugar Markers

Improvement in lipid profile – reduction in total cholesterol and triglycerides

Diabetic Nephropathy – Reducing Oxidative Stress and Inflammation

Bone Health – In Combination with Organic Vanadium: β-Cell Regeneration and Improved Bone Strength

Complementary Cancer Treatment – The Tumor Inhibitor

Particularly effective against hormone-dependent tumors

Androgen-dependent prostate cancer – In vitro:

Inhibition of cell proliferation – Arrest of growth

Inhibition of PSA secretion – Reduction of prostate-specific antigen

Estrogen-dependent breast cancer – In vitro:

ER+ and ER- Cell Growth – Inhibition of Both Types of Breast Cancer Cells

Apoptosis Induction – Programmed Cell Death

Inhibition of tumor formation – Prevention of tumor development

Other types of cancer – In vitro:

Ovarian Cancer – Induction of Apoptosis

Gastric cancer – Inhibition of colony formation in cell lines

Hepatocellular carcinoma – Antiproliferative effect

Glioblastoma – Cytotoxic and DNA synthesis-inhibiting effects

T-cell leukemia – Antileukemic activity

Prostate Diseases – The Prostate Specialist

Benign Prostatic Hyperplasia – Promising Antiandrogenic Effect

Androgen receptor reduction – In vitro concentration reduction

PSA Gene Expression – Reduced Gene Activity

Hepatoprotective effect – The liver protector

Alcohol-related liver disease – Improvement of alcohol metabolism disorders in animal studies

Oxidative stress – Alleviating processes that damage the liver

Dyslipidemia – Improvement of Abnormal Lipid Levels

Liver Lipid Metabolism – Normalization of Metabolic Disorders

Prebiotic effect – Positive changes in gut microbiota with a reduction in liver inflammation and insulin resistance

Weight Management – The Metabolism Optimizer

Weight Management – Support for Weight Control

Antimicrobial Effect – The Germ Fighter

Bacterial infections – In vitro inhibitory effects against:

Staphylococcus aureus – Impaired biofilm formation

Pseudomonas aeruginosa – Growth inhibition

Multidrug-resistant Gram-positive bacteria – Bacillus species

Fungal infections – Antifungal activity against:

Aspergillus niger – Mold inhibition

Candida albicans – Combating Yeast Infections

Skin Health – The Skin Enhancer

Skin Aging – Antioxidant Effects

Moisturizing – Skin-nourishing properties

Skin Lightening – Reduction of Hyperpigmentation

UV-B protection – Reduction of UV-B-induced skin inflammation

Neuroprotective effect – The brain protector

Anti-AChE activity – Reversible acetylcholinesterase inhibition, comparable to donepezil

Alzheimer's Potential – Possible Therapeutic Applications

Lewy Body Dementia – Potential Treatment Support

Gut Health – The Digestive Aid

Traditional Applications – The Time-Tested Range

Improved Digestion – Optimizing Digestive Function

Flatulence – Reducing Gas Buildup

Constipation – Promoting Bowel Movement

Hemorrhoids – Therapeutic Support

Gut Health – Primary Area of Application

Promoting Digestion – Improving Gastrointestinal Function

Gastrointestinal complaints – Treatment of digestive disorders

Metabolic Support – Regulation of Metabolic Processes

Bioactive Ingredients

L-Ergothioneine – The Super Antioxidant

Powerful antioxidant – protects cells from oxidative stress

Neuroprotective – Protection of nerve cells

Anti-inflammatory – Reduction of chronic inflammatory processes

Tumor-suppressing – Anticarcinogenic properties

Comatin – The Diabetes Specialist

Antidiabetic – Blood sugar regulation

Antihyperglycemic – Control of elevated blood sugar levels

Lipid-lowering – reduction of cholesterol and triglyceride levels

HIV-1 Inhibition – Antiviral Effect

Vanadium – The Insulin Mimic

Insulin-mimetic – Enhancement of the blood-sugar-lowering effect by mimicking insulin

Antioxidant – Protection against free radicals

Antimicrobial – Inhibition of pathogenic microorganisms

Coprin – The Mycotoxin

Acetaldehyde – Dehydrogenase Inhibition

Vitamin C – The Cell Protector

Antioxidant – Protection against oxidative damage

Trehalose – The Gut Care Specialist

Prebiotic – Promotes healthy gut flora

Citric Acid – The Blood Sugar Regulator

Antidiabetic – Supports blood sugar control

CCP (Coprinus comatus polysaccharides, β-glucans) – The All-Rounders

Prebiotic – Supports gut flora

Antidiabetic – Blood sugar regulation

Antioxidant – Cell protection

Anti-inflammatory – Anti-inflammatory effect

Hepatoprotective – Protects liver cells

Antibacterial – Antimicrobial Properties

Antimicrobial compounds – The germ fighters

Coprinin, coprinol – formed during fermentation

Coprinuslactone – Additional antimicrobial effect

Laccase – The HIV Inhibitor

Inhibition of HIV-1 activity – Limited antiviral effect

Phenols and aromatic molecules – The Relaxants

3-Octanone, 3-Octanol, 1-Octen-3-ol, 1-Octanol, l-Dodecanol

Antioxidant – Cell protection

Antitumor – Cancer-inhibiting properties

Emotional Relief – Reducing Anxiety and Promoting Relaxation After Extraction

Caprylic acid, n-butyric acid, isobutyric acid – Additional therapeutic components

Nutritional Profile – The Nutrition Package

Macronutrients:

Moisture content: 90.5%

Protein: 11.8–29.5 g/100 g

Fat: 1.1–7.3 g per 100 g

Carbohydrates: 32.1–76.3 g/100 g

Dietary fiber: 21.13–34.59 g/100 g

Ash: 13.24 g/100 g

Minerals:

Iron (Fe)

Calcium (Ca)

Zinc (Zn)

Magnesium (Mg)

Phosphorus (P)

Safety considerations

Coprinus Syndrome – Alcohol Intolerance

Trigger – consumption in combination with alcohol

Mechanism – Inhibition of acetaldehyde dehydrogenase by mycotoxins

Symptoms:

Ethanol intolerance – Alcohol intolerance

Skin redness – flushing reactions

Metallic taste – taste disorders

Tachycardia – Rapid heartbeat

Headaches – Cephalgia

Dizziness – Vertigo

Vomiting – Nausea and Emesis

Sweating – Hyperhidrosis

Fasciculations – muscle twitches

Orthostatic hypotension – a drop in blood pressure upon standing

Collapse – Circulatory failure

Skin reactions – Allergic reactions

At-risk population – patients with dermatitis and an atopic predisposition

Prevalence – 32% of patients with atopic dermatitis

Reaction Type – Delayed-Type Reactions

Test procedure – Atopic patch test (5 mg of cap protein per 1 g of petroleum jelly or 1.35 mg of spore protein per 1 g of petroleum jelly)

References

Coprinus – An Overview | ScienceDirect Topics [Internet]. [Cited January 18, 2022]. Available at:https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/coprinusbenwirkungen and Safety Precautions

Martin Powell. Medicinal Mushrooms. [Internet]. Place of publication not specified: Mycology Press; [cited December 27, 2021]. Available at: https://www.hoopladigital.com/title/11571096

Bianchi I, Marrocchesi R. Healing with Medicinal Mushrooms: Therapeutic Properties and Guidelines for the 12 Most Important Medicinal Mushrooms. Treviso: Editoriale Programma; 2015.

Guthmann, J. Healing Mushrooms: The World’s Most Important Species: Description – Components – Effects. 2nd, updated and expanded edition. Wiebelsheim: Quelle & Meyer Verlag; 2021. 446 pp.

Rogers, RD. The Fungal Pharmacy: The Complete Guide to Medicinal Mushrooms and Lichens of North America. Berkeley, California: North Atlantic Books; 2011. 591 pp.

Nachimuthu S, Kandasamy R, Ponnusamy R, Deruiter J, Dhanasekaran M, Thilagar S. L-Ergothioneine: A Potential Bioactive Compound from Edible Mushrooms. In: Agrawal DC, Dhanasekaran M, eds. Medicinal Mushrooms: Recent Advances in Research and Development [Internet]. Singapore: Springer; 2019 [cited 2022 Jan 18]. pp. 391–407. Available from: https://doi.org/10.1007/978-981-13-6382-5_16

Asahi T, Wu X, Shimoda H, Hisaka S, Harada E, Kanno T, et al. Ergothioneine, an amino acid derived from fungi, is a potential inhibitor of inflammation-induced DNA halogenation. Bioscience, Biotechnology, and Biochemistry. February 1, 2016;80(2):313–7.

Rebensburg, P., & Kappl, A. Healthy with Medicinal Mushrooms: Strengthen Your Immune System, Cure Diseases, and Alleviate Symptoms. Munich: riva; 2020. 271 p.

Cao H, Qin D, Guo H, Cui X, Wang S, Wu Y, et al. The Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus (Agaricomycetes), a Versatile Functional Species: A Review. Int J Med Mushrooms. 2020;22(3):245–55.

Han C, Liu T. A comparison of the hypoglycemic activity of three species of basidiomycetes rich in vanadium. Biol Trace Elem Res. February 2009;127(2):177–82.

Lv Y, Han L, Yuan C, Guo J. Comparison of the hypoglycemic activity of trace elements absorbed in fermented Coprinus comatus mushrooms. Biol Trace Elem Res. November 2009;131(2):177–85.

Han C, Yuan J, Wang Y, Li L. Hypoglycemic activity of a fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol. 2006;20(3):191–6.

Zhou G, Han C. The combined effect of vanadium and fermented Coprinus comatus mushrooms on glycemic metabolism. Biol Trace Elem Res. July 2008;124(1):20–7.

Han C, Cui B, Wang Y. Vanadium uptake by the biomass of Coprinus comatus and its effect on hyperglycemic mice. Biol Trace Elem Res. July 2008;124(1):35–9.

Matthies L, Laatsch H. Unusual mushroom poisoning: Coprin, an inhibitor of alcohol metabolism. Pharmacy in Our Time. 1992;21(1):14–20.

Dr. Walter Ardigò. Healing with Medicinal Mushrooms. A Practical Handbook. Youcanprint; 2017. 394 p.

Karaman M, Tesanovic K, Gorjanovic S, Pastor FT, Simonovic M, Glumac M, et al. Polarography as the technique of choice for assessing total antioxidant activity: A case study of selected Coprinus comatus extracts and quinic acid, their antidiabetic component. Nat Prod Res. May 2021; 35(10):1711–6.

Li W, Wang Y, Sun M, Liang Y, Wang X, Qi D, et al. The medicinal mushroom Coprinus comatus (Agaricomycetes), whose protein attenuates acute alcoholic liver injury in conjunction with changes in the gut microbiota of mice. Int J Med Mushrooms. 2021;23(5):91–100.

Wang S, Wang C, Cao H, Cui X, Guo H, Zheng W, et al. Comparison of the cosmetic effects of liquid-fermented cultures of several medicinal mushrooms, including antioxidant, moisturizing, and skin-brightening properties. Int J Med Mushrooms. 2020;22(7):693–703.

Ramesh S, Majrashi M, Almaghrabi M, Govindarajulu M, Fahoury E, Fadan M, et al. Overview of the therapeutic efficacy of mushrooms. In: Agrawal DC, Dhanasekaran M, eds. Medicinal Mushrooms [Internet]. Singapore: Springer Singapore; 2019 [cited 2022 Jan 16]. pp. 103–41. Available from: http://link.springer.com/10.1007/978-981-13-6382-5_3

Stilinović N, Čapo I, Vukmirović S, Rašković A, Tomas A, Popović M, et al. Chemical composition, nutritional profile, and in vivo antioxidant properties of the cultivated mushroom Coprinus comatus. R Soc Open Sci. September 2020; 7(9):200900.

Nowakowski P, Naliwajko SK, Markiewicz-Żukowska R, Borawska MH, Socha K. The Two Faces of Coprinus comatus – Functional Properties and Potential Hazards. Phytotherapy Research. November 2020; 34(11):2932–44.

Husen F, Hernayanti H, Ekowati N, Sukmawati D, Ratnaningtyas NI. Antidiabetic effects and antioxidant properties of the medicinal mushroom Coprinus comatus (Agaricomycetes) in streptozotocin-induced hyperglycemia in rats. Int J Med Mushrooms. 2021;23(10):9–21.

Gao Z, Kong D, Cai W, Zhang J, Jia L. Characterization and antidiabetic and nephroprotective effects of mycelial polysaccharides from Coprinus comatus. Carbohydrate Polymers. January 2021;251:117081.

Stajić M, Vukojević J, Ćilerdžić J. Mushrooms as potential natural cytostatic agents. In: Agrawal DC, Dhanasekaran M, eds. Medicinal Mushrooms [Internet]. Singapore: Springer Singapore; 2019 [cited 2021 Dec 27]. pp. 143–68. Available from: http://link.springer.com/10.1007/978-981-13-6382-5_4

Zaidman B-Z, Wasser SP, Nevo E, Mahajna J. Coprinus comatus and Ganoderma lucidum impair androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep. June 2008; 35(2):107–17.

Dotan N, Wasser SP, Mahajna J. Inhibition of androgen receptor activity by compounds from Coprinus comatus. Nutrition and Cancer. November 2011; 63(8):1316–27.

Dotan N, Wasser SP, Mahajna J. The edible and medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator. Integr Cancer Ther. June 2011; 10(2):148–59.

Gu Y-H, Leonard J. In vitro effects of selected fungal species on proliferation, apoptosis, and colony inhibition in ER-dependent and ER-independent human breast cancer cells. Oncology Reports. February 1, 2006; 15(2):417–23.

Asatiani MD, Wasser SP, Nevo ED, Ruimi N, Mahajna JA, Reznick A. The medicinal mushroom Coprinus comatus (O.F. Mull.: Fr.) Pers. (Agaricomycetideae) disrupts H₂O₂-induced activation of the NF-κB pathway by inhibiting IκBα phosphorylation in MCF7 breast cancer cells. Int J Med Mushrooms [Internet]. 2011 [cited 2022 Jan 18];13. Available from: https://www.dl.begellhouse.com/references/708ae68d64b17c52,77c52f4810e4b47b,4c5e3d861c1bdd9f.html

Wong JH, Ng TB, Chan HHL, Liu Q, Man GCW, Zhang CZ, et al. Fungal extracts and compounds with inhibitory effects on breast cancer: Findings from studies using cultured cancer cells, tumor-bearing animals, and clinical trials. Appl Microbiol Biotechnol. June 2020;104(11):4675–703.

Nowakowski P, Markiewicz-Żukowska R, Gromkowska-Kępka K, Naliwajko SK, Moskwa J, Bielecka J, et al. Fungi as potential therapeutic agents in cancer treatment: Evaluation of the anti-glioma activity of extracts from Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum, and Lactarius deliciosus. Biomedicine & Pharmacotherapy. January 2021; 133:111090..

Li W, Wang Y, Sun M, Liang Y, Cai X, Qi D, et al. The prebiotic effects of Coprinus comatus polysaccharides on the gut microbiota in normal mice and those with acute alcoholic liver injury: A comparative study. Evid Based Complement Alternat Med. 2020;2020:2027570.

Karaman M, Tesanovic K, Novakovic A, Jakovljevic D, Janjusevic L, Sibul F, et al. Coprinus comatus filtrate extract, a novel neuroprotective agent of natural origin. Nat Prod Res. August 2020;34(16):2346–50.

Coprinus Syndrome – Alcohol Intolerance

Trigger – consumption in combination with alcohol

Mechanism – Inhibition of acetaldehyde dehydrogenase by mycotoxins

Symptoms:

Ethanol intolerance – Alcohol intolerance

Skin redness – flushing reactions

Metallic taste – taste disorders

Tachycardia – Rapid heartbeat

Headaches – Cephalgia

Dizziness – Vertigo

Vomiting – Nausea and Emesis

Sweating – Hyperhidrosis

Fasciculations – muscle twitches

Orthostatic hypotension – a drop in blood pressure upon standing

Collapse – Circulatory failure

Skin reactions – Allergic reactions

At-risk population – patients with dermatitis and an atopic predisposition

Prevalence – 32% of patients with atopic dermatitis

Reaction Type – Delayed-Type Reactions

Test procedure – Atopic patch test (5 mg of cap protein per 1 g of petroleum jelly or 1.35 mg of spore protein per 1 g of petroleum jelly)

References

  1. Martin Powell. Medicinal Mushrooms. [Internet]. Place of publication not specified: Mycology Press; [cited December 27, 2021]. Available at: https://www.hoopladigital.com/title/11571096
  2. Bianchi I, Marrocchesi R. Healing with Medicinal Mushrooms: Therapeutic Properties and Guidelines for the 12 Most Important Medicinal Mushrooms. Treviso: Editoriale Programma; 2015.
  3. Guthmann, J. Healing Mushrooms: The World’s Most Important Species: Description – Components – Effects. 2nd, updated and expanded edition. Wiebelsheim: Quelle & Meyer Verlag; 2021. 446 pp.
  4. Rogers, RD. The Fungal Pharmacy: The Complete Guide to Medicinal Mushrooms and Lichens of North America. Berkeley, California: North Atlantic Books; 2011. 591 pp.
  5. Nachimuthu S, Kandasamy R, Ponnusamy R, Deruiter J, Dhanasekaran M, Thilagar S. L-Ergothioneine: A Potential Bioactive Compound from Edible Mushrooms. In: Agrawal DC, Dhanasekaran M, eds. Medicinal Mushrooms: Recent Advances in Research and Development [Internet]. Singapore: Springer; 2019 [cited 2022 Jan 18]. pp. 391–407. Available from: https://doi.org/10.1007/978-981-13-6382-5_16
  6. Asahi T, Wu X, Shimoda H, Hisaka S, Harada E, Kanno T, et al. Ergothioneine, an amino acid derived from fungi, is a potential inhibitor of inflammation-induced DNA halogenation. Bioscience, Biotechnology, and Biochemistry. February 1, 2016;80(2):313–7.
  7. Rebensburg, P., & Kappl, A. Healthy with Medicinal Mushrooms: Strengthen Your Immune System, Cure Diseases, and Alleviate Symptoms. Munich: riva; 2020. 271 p.
  8. Cao H, Qin D, Guo H, Cui X, Wang S, Wu Y, et al. The Shaggy Ink Cap Medicinal Mushroom, Coprinus comatus (Agaricomycetes), a Versatile Functional Species: A Review. Int J Med Mushrooms. 2020;22(3):245–55.
  9. Han C, Liu T. A comparison of the hypoglycemic activity of three species of basidiomycetes rich in vanadium. Biol Trace Elem Res. February 2009;127(2):177–82.
  10. Lv Y, Han L, Yuan C, Guo J. Comparison of the hypoglycemic activity of trace elements absorbed in fermented Coprinus comatus mushrooms. Biol Trace Elem Res. November 2009;131(2):177–85.
  11. Han C, Yuan J, Wang Y, Li L. Hypoglycemic activity of a fermented mushroom of Coprinus comatus rich in vanadium. J Trace Elem Med Biol. 2006;20(3):191–6.
  12. Zhou G, Han C. The combined effect of vanadium and fermented Coprinus comatus mushrooms on glycemic metabolism. Biol Trace Elem Res. July 2008;124(1):20–7.
  13. Han C, Cui B, Wang Y. Vanadium uptake by the biomass of Coprinus comatus and its effect on hyperglycemic mice. Biol Trace Elem Res. July 2008;124(1):35–9.
  14. Matthies L, Laatsch H. Unusual mushroom poisoning: Coprin, an inhibitor of alcohol metabolism. Pharmacy in Our Time. 1992;21(1):14–20.
  15. Dr. Walter Ardigò. Healing with Medicinal Mushrooms. A Practical Handbook. Youcanprint; 2017. 394 p.
  16. Karaman M, Tesanovic K, Gorjanovic S, Pastor FT, Simonovic M, Glumac M, et al. Polarography as the technique of choice for assessing total antioxidant activity: A case study of selected Coprinus comatus extracts and quinic acid, their antidiabetic component. Nat Prod Res. May 2021; 35(10):1711–6.
  17. Li W, Wang Y, Sun M, Liang Y, Wang X, Qi D, et al. The medicinal mushroom Coprinus comatus (Agaricomycetes), whose protein attenuates acute alcoholic liver injury in conjunction with changes in the gut microbiota of mice. Int J Med Mushrooms. 2021;23(5):91–100.
  18. Wang S, Wang C, Cao H, Cui X, Guo H, Zheng W, et al. Comparison of the cosmetic effects of liquid-fermented cultures of several medicinal mushrooms, including antioxidant, moisturizing, and skin-brightening properties. Int J Med Mushrooms. 2020;22(7):693–703.
  19. Ramesh S, Majrashi M, Almaghrabi M, Govindarajulu M, Fahoury E, Fadan M, et al. Overview of the therapeutic efficacy of mushrooms. In: Agrawal DC, Dhanasekaran M, eds. Medicinal Mushrooms [Internet]. Singapore: Springer Singapore; 2019 [cited 2022 Jan 16]. pp. 103–41. Available from: http://link.springer.com/10.1007/978-981-13-6382-5_3
  20. Stilinović N, Čapo I, Vukmirović S, Rašković A, Tomas A, Popović M, et al. Chemical composition, nutritional profile, and in vivo antioxidant properties of the cultivated mushroom Coprinus comatus. R Soc Open Sci. September 2020; 7(9):200900.
  21. Nowakowski P, Naliwajko SK, Markiewicz-Żukowska R, Borawska MH, Socha K. The Two Faces of Coprinus comatus – Functional Properties and Potential Hazards. Phytotherapy Research. November 2020; 34(11):2932–44.
  22. Husen F, Hernayanti H, Ekowati N, Sukmawati D, Ratnaningtyas NI. Antidiabetic effects and antioxidant properties of the medicinal mushroom Coprinus comatus (Agaricomycetes) in streptozotocin-induced hyperglycemia in rats. Int J Med Mushrooms. 2021;23(10):9–21.
  23. Gao Z, Kong D, Cai W, Zhang J, Jia L. Characterization and antidiabetic and nephroprotective effects of mycelial polysaccharides from Coprinus comatus. Carbohydrate Polymers. January 2021;251:117081.
  24. Stajić M, Vukojević J, Ćilerdžić J. Mushrooms as potential natural cytostatic agents. In: Agrawal DC, Dhanasekaran M, eds. Medicinal Mushrooms [Internet]. Singapore: Springer Singapore; 2019 [cited 2021 Dec 27]. pp. 143–68. Available from: http://link.springer.com/10.1007/978-981-13-6382-5_4
  25. Zaidman B-Z, Wasser SP, Nevo E, Mahajna J. Coprinus comatus and Ganoderma lucidum impair androgen receptor function in LNCaP prostate cancer cells. Mol Biol Rep. June 2008; 35(2):107–17.
  26. Dotan N, Wasser SP, Mahajna J. Inhibition of androgen receptor activity by compounds from Coprinus comatus. Nutrition and Cancer. November 2011; 63(8):1316–27.
  27. Dotan N, Wasser SP, Mahajna J. The edible and medicinal mushroom Coprinus comatus as a natural antiandrogenic modulator. Integr Cancer Ther. June 2011; 10(2):148–59.
  28. Gu Y-H, Leonard J. In vitro effects of selected fungal species on proliferation, apoptosis, and colony inhibition in ER-dependent and ER-independent human breast cancer cells. Oncology Reports. February 1, 2006; 15(2):417–23.
  29. Asatiani MD, Wasser SP, Nevo ED, Ruimi N, Mahajna JA, Reznick A. The medicinal mushroom Coprinus comatus (O.F. Mull.: Fr.) Pers. (Agaricomycetideae) disrupts H₂O₂-induced activation of the NF-κB pathway by inhibiting IκBα phosphorylation in MCF7 breast cancer cells. Int J Med Mushrooms [Internet]. 2011 [cited 2022 Jan 18];13. Available from: https://www.dl.begellhouse.com/references/708ae68d64b17c52,77c52f4810e4b47b,4c5e3d861c1bdd9f.html
  30. Wong JH, Ng TB, Chan HHL, Liu Q, Man GCW, Zhang CZ, et al. Fungal extracts and compounds with inhibitory effects on breast cancer: Findings from studies using cultured cancer cells, tumor-bearing animals, and clinical trials. Appl Microbiol Biotechnol. June 2020;104(11):4675–703.
  31. Nowakowski P, Markiewicz-Żukowska R, Gromkowska-Kępka K, Naliwajko SK, Moskwa J, Bielecka J, et al. Fungi as potential therapeutic agents in cancer treatment: Evaluation of the anti-glioma activity of extracts from Coprinus comatus, Cantharellus cibarius, Lycoperdon perlatum, and Lactarius deliciosus. Biomedicine & Pharmacotherapy. January 2021; 133:111090..
  32. Li W, Wang Y, Sun M, Liang Y, Cai X, Qi D, et al. The prebiotic effects of Coprinus comatus polysaccharides on the gut microbiota in normal mice and those with acute alcoholic liver injury: A comparative study. Evid Based Complement Alternat Med. 2020;2020:2027570.
  33. Karaman M, Tesanovic K, Novakovic A, Jakovljevic D, Janjusevic L, Sibul F, et al. Coprinus comatus filtrate extract, a novel neuroprotective agent of natural origin. Nat Prod Res. August 2020;34(16):2346–50.
  34. Coprinus – An Overview | ScienceDirect Topics [Internet]. [Cited January 18, 2022]. Available at: https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/coprinus

Contents

Sign up for our newsletter. No spam, no sharing of your information—just the latest news and interesting facts from the world of mushrooms. You can unsubscribe at any time.

Mycoverse Foundation
, Marktgass 11,
, 9490 Vaduz,
, Principality of Liechtenstein

info@mycoverse-foundation.org

MYCOVERSE Logo